Hundreds of Patients Wrongly Diagnosed with Cancer Due to Software Mix-up
Scrubs
JUNE 12, 2023
The biotech firm known as Grail made headlines earlier this year thanks to its signature Galleri blood tests, which can detect up to 50 different kinds of cancer early on to improve patient outcomes. The tests were hailed as the “first of its kind” when it hit the market in 2023. It’s that they simply didn’t exist.
Let's personalize your content